Kimberly J. Toomire

Kimberly Toomire practices at Northern Light Sebasticook Valley Hospital in Pittsfield, Maine, part of Northern Light Health.

Kimberly Toomire's NPI, 1831726421, was assigned on March 24, 2020. Kimberly Toomire graduated from University of New England, College of Osteo Medicine in 2020. Kimberly Toomire holds Maine license DO3623.

Kimberly Toomire's primary practice is Northern Light Sebasticook Valley Hospital, at 447 North Main Street, Pittsfield, ME 04967 in Somerset County. The practice phone is (207) 487-5141.

Kimberly Toomire's primary practice is Northern Light Sebasticook Valley Hospital in Pittsfield, Maine, part of Northern Light Health. Kimberly Toomire is also affiliated with MaineHealth Maine Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Kimberly Toomire to 1 more breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimberly Toomire practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kimberly Toomire's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kimberly Toomire is licensed in Maine.

CMS data shows 80 Medicare services from Kimberly Toomire across 3 procedure codes in 2024, for 39 Medicare patients. Medicare paid $4,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Kimberly Toomire in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 69% have mood disorders. 54% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kimberly Toomire's median patient age at 68, with 38% women.

In 2024, Kimberly Toomire wrote 86 Medicare Part D claims for 31 patients. 92% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $179 in total drug cost. In 2022, CMS named 88 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Kimberly Toomire for performance year 2024, reported through an alternative payment model (APM). Kimberly Toomire accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Kimberly Toomire, published from 2013 to 2020. 2016 was the busiest year, with 2. The most frequent topics are DNA Damage, DNA Repair and BRCA1 Protein. Kimberly Toomire's most frequent co-author is Yiduo Hu, MD, PhD.

CMS Open Payments shows 1 general payment to Kimberly Toomire from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Tempus AI, Inc paid the most, $30.

Kimberly Toomire graduated from University of New England, College of Osteo Medicine in 2020.